Manufacturing delays and increased demand have left many families in the Mid-South unable to fill their prescriptions. In response, the FDA has approved several generic versions of the drug Vyvanse
Drugmakers have begun shipping copycat versions of Takeda Pharmaceutical s drug Vyvanse, which is expected to offset the ongoing shortage of the ADHD medicine in the United States.
The Biden administration revealed plans to seek lower prices for widely used diabetes, cancer, and arthritis drugs as well as clot preventers amid continuing industry opposition to negotiations.
Drugmakers are bracing for the US government s announcement of the 10 prescription medicines that will be subject to the first-ever price negotiations by the Medicare health program.